Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Clinical trial NCT05934526 · COMPLETED

Trial details

NCT number: NCT05934526
Sponsor: GB002, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2023-12-28
Primary completion: 2025-11-27
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.